Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Fidia Spa ( (IT:FDA) ) has shared an announcement.
Fidia S.p.A. has reported a new step in the execution of its convertible bond loan reserved for Global Growth Holding Limited, with the conversion of two bonds from the fourth tranche into 2,000,000 new shares at €0.01 per share. Following this transaction, the company’s share capital rises by €20,000 to €10,767,761.90, and the total number of shares increases to 51,542,927, reflecting ongoing dilution as the POC progresses, with eight bonds subscribed but not yet converted and the related capital increase to be partially registered with the Turin Companies Register in line with legal requirements.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.11 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A., based in Turin and listed on Euronext Milan, is a global player in high-performance integrated milling systems, numerical controls and CAM software. Its solutions serve mainly the mould sector for the automotive industry and the aerospace sector, covering the entire milling process from machining program definition to finished product, and the group employs around 135 people.
Average Trading Volume: 1,421,178
Technical Sentiment Signal: Strong Sell
Current Market Cap: €711.8K
For a thorough assessment of FDA stock, go to TipRanks’ Stock Analysis page.

